GHK-Cu + KPV Blend

Buy GHK-Cu + KPV Blend Online

GHK-Cu + KPV Blend combines GHK-Cu (Copper Tripeptide-1) with KPV (Lys-Pro-Val) in a two-peptide research formulation. The individual peptides have distinct research profiles involving extracellular-matrix biology, skin remodeling, inflammation, and tissue repair.

Product Information

GHK-Cu is a copper-binding tripeptide extensively studied in skin and connective-tissue research. At the same time, KPV is the C-terminal tripeptide of alpha-MSH and has primarily been investigated in cellular and animal inflammation models. Current research-market formulations vary in composition, with reported combinations including 50 mg GHK-Cu + 10 mg KPV and 50 mg GHK-Cu + 20 mg KPV. There is no standardized formulation across suppliers.

How It Works

GHK-Cu is associated with extracellular matrix and collagen-related signaling, while KPV has been investigated for anti-inflammatory effects downstream of melanocortin pathways. The two peptides therefore represent complementary but distinct biological pathways.

POTENTIAL BENEFITS

1. Collagen Research

GHK-Cu has been studied extensively for its effects on collagen synthesis, fibroblast activity, and extracellular-matrix remodeling. These properties make it particularly relevant to skin and connective-tissue research.

2. Skin Remodeling Research

Research involving copper tripeptides has examined wound repair, skin structure, and tissue remodeling. GHK-Cu therefore provides the primary skin-focused component of this blend.

3. Inflammation Research

KPV has been investigated in experimental models of intestinal and cellular inflammation. Research has examined pathways involving inflammatory cytokines and NF-κB-related signaling.

4. Tissue-Repair Research

The individual components have been studied in different tissue-repair models, giving the combination a broader research profile spanning extracellular-matrix biology and inflammatory regulation.

Dosage

There is no established clinical dosage for the GHK-Cu + KPV combination. Current research-market formulations vary in their component ratios, and no controlled human study has established a validated dose for the premixed combination.

Side Effects

The safety profile of the complete combination has not been established in controlled human trials. GHK-Cu has the stronger human/topical research base, while KPV remains predominantly preclinical, so evidence for one component should not be interpreted as evidence for the complete blend.

References

1. GHK-Cu + KPV Blend — formulation and research overview
2. GHK-Cu + KPV Blend — ingredients and ratios
3. GHK-Cu connective-tissue research — PubMed
4. GHK-Cu and skin/wound-healing research — PubMed
5. KPV inflammatory-pathway research — PubMed

Note: BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.

Please click here to see how purchases actually work on this site.